(Q73479840)

English

Inhibitory effect of orally administered donepezil hydrochloride (E2020), a novel treatment for Alzheimer's disease, on cholinesterase activity in rats

scientific article published on 01 February 2000

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10688981%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Inhibitory effect of orally administered donepezil hydrochloride (E2020), a novel treatment for Alzheimer's disease, on cholinesterase activity in rats (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10688981%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Alzheimer's disease

1 reference

based on heuristic

inferred from title

author name string

T Kosasa

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10688981%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Y Kuriya

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10688981%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

K Matsui

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10688981%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Y Yamanishi

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10688981%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

language of work or name

0 references

publication date

1 February 2000

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10688981%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

European Journal of Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10688981%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

389

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10688981%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

2-3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10688981%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

173-179

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10688981%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Role of butyrylcholinesterase in canine tracheal smooth muscle function

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900876-6

7 January 2021

Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900876-6

7 January 2021

Comparison of butyrylcholinesterase and acetylcholinesterase

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900876-6

7 January 2021

Selective loss of central cholinergic neurons in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900876-6

7 January 2021

Tacrine slows the rate of ageing of sarin-inhibited acetylcholinesterase

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900876-6

7 January 2021

Memory and cognitive function in man: Does the cholinergic system have a specific role?

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900876-6

7 January 2021

Divergent regulation of acetylcholinesterase and butyrylcholinesterase in tissues of the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900876-6

7 January 2021

A new and rapid colorimetric determination of acetylcholinesterase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900876-6

7 January 2021

Brain selective inhibition of acetylcholinesterase: a novel approach to therapy for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900876-6

7 January 2021

The cholinergic pharmacology of tetrahydroaminoacridine in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900876-6

7 January 2021

Effect of donepezil hydrochloride (E2020) on basal concentration of extracellular acetylcholine in the hippocampus of rats

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900876-6

7 January 2021

Effect of donepezil hydrochloride (E2020) on extracellular acetylcholine concentration in the cerebral cortex of rats

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900876-6

7 January 2021

Molecular and cellular biology of cholinesterases

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900876-6

7 January 2021

Neurotransmitter enzyme abnormalities in senile dementia. Choline acetyltransferase and glutamic acid decarboxylase activities in necropsy brain tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900876-6

7 January 2021

Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900876-6

7 January 2021

Donepezil improves cognition and global function in Alzheimer disease: a 15-week, double-blind, placebo-controlled study. Donepezil Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900876-6

7 January 2021

A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900876-6

7 January 2021

Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease: an interim analysis of the results of a US multicentre open label extension study

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900876-6

7 January 2021

Synthesis and structure-activity relationships of acetylcholinesterase inhibitors: 1-benzyl-4-[(5,6-dimethoxy-1-oxoindan-2-yl)methyl]piperidine hydrochloride and related compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900876-6

7 January 2021

A suitable method to monitor inhibition of cholinesterase activities in tissues as induced by reversible enzyme inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900876-6

7 January 2021

Changes in the levels and forms of rat plasma cholinesterases during chronic diisopropylphosphorofluoridate intoxication

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900876-6

7 January 2021

Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900876-6

7 January 2021

Identifiers

10.1016/S0014-2999(99)00876-6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10688981%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10688981%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73479840&oldid=1781971543"